Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma
One of the challenges to the management of severe asthma is the poor therapeutic response to treatment with glucocorticosteroids. Compounds derived from marine sources have received increasing interest in recent years due to their prominent biologically active properties for biomedical applications,...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0917cc815806475a8a6144673059200d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0917cc815806475a8a6144673059200d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0917cc815806475a8a6144673059200d2021-11-25T18:12:36ZMarine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma10.3390/md191105861660-3397https://doaj.org/article/0917cc815806475a8a6144673059200d2021-10-01T00:00:00Zhttps://www.mdpi.com/1660-3397/19/11/586https://doaj.org/toc/1660-3397One of the challenges to the management of severe asthma is the poor therapeutic response to treatment with glucocorticosteroids. Compounds derived from marine sources have received increasing interest in recent years due to their prominent biologically active properties for biomedical applications, as well as their sustainability and safety for drug development. Based on the pathobiological features associated with glucocorticoid resistance in severe asthma, many studies have already described many glucocorticoid resistance mechanisms as potential therapeutic targets. On the other hand, in the last decade, many studies described the potentially anti-inflammatory effects of marine-derived biologically active compounds. Analyzing the underlying anti-inflammatory mechanisms of action for these marine-derived biologically active compounds, we observed some of the targeted pathogenic molecular mechanisms similar to those described in glucocorticoid (GC) resistant asthma. This article gathers the marine-derived compounds targeting pathogenic molecular mechanism involved in GC resistant asthma and provides a basis for the development of effective marine-derived drugs.Cristina Mihaela GhiciucAndrei Gheorghe VicovanCelina Silvia StafieSabina Antonela AntoniuParaschiva PostolacheMDPI AGarticlemarine-derived compoundsglucocorticoid-resistantsevere asthmadrug developmentbiomedical applicationsBiology (General)QH301-705.5ENMarine Drugs, Vol 19, Iss 586, p 586 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
marine-derived compounds glucocorticoid-resistant severe asthma drug development biomedical applications Biology (General) QH301-705.5 |
spellingShingle |
marine-derived compounds glucocorticoid-resistant severe asthma drug development biomedical applications Biology (General) QH301-705.5 Cristina Mihaela Ghiciuc Andrei Gheorghe Vicovan Celina Silvia Stafie Sabina Antonela Antoniu Paraschiva Postolache Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
description |
One of the challenges to the management of severe asthma is the poor therapeutic response to treatment with glucocorticosteroids. Compounds derived from marine sources have received increasing interest in recent years due to their prominent biologically active properties for biomedical applications, as well as their sustainability and safety for drug development. Based on the pathobiological features associated with glucocorticoid resistance in severe asthma, many studies have already described many glucocorticoid resistance mechanisms as potential therapeutic targets. On the other hand, in the last decade, many studies described the potentially anti-inflammatory effects of marine-derived biologically active compounds. Analyzing the underlying anti-inflammatory mechanisms of action for these marine-derived biologically active compounds, we observed some of the targeted pathogenic molecular mechanisms similar to those described in glucocorticoid (GC) resistant asthma. This article gathers the marine-derived compounds targeting pathogenic molecular mechanism involved in GC resistant asthma and provides a basis for the development of effective marine-derived drugs. |
format |
article |
author |
Cristina Mihaela Ghiciuc Andrei Gheorghe Vicovan Celina Silvia Stafie Sabina Antonela Antoniu Paraschiva Postolache |
author_facet |
Cristina Mihaela Ghiciuc Andrei Gheorghe Vicovan Celina Silvia Stafie Sabina Antonela Antoniu Paraschiva Postolache |
author_sort |
Cristina Mihaela Ghiciuc |
title |
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
title_short |
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
title_full |
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
title_fullStr |
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
title_full_unstemmed |
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma |
title_sort |
marine-derived compounds for the potential treatment of glucocorticoid resistance in severe asthma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/0917cc815806475a8a6144673059200d |
work_keys_str_mv |
AT cristinamihaelaghiciuc marinederivedcompoundsforthepotentialtreatmentofglucocorticoidresistanceinsevereasthma AT andreigheorghevicovan marinederivedcompoundsforthepotentialtreatmentofglucocorticoidresistanceinsevereasthma AT celinasilviastafie marinederivedcompoundsforthepotentialtreatmentofglucocorticoidresistanceinsevereasthma AT sabinaantonelaantoniu marinederivedcompoundsforthepotentialtreatmentofglucocorticoidresistanceinsevereasthma AT paraschivapostolache marinederivedcompoundsforthepotentialtreatmentofglucocorticoidresistanceinsevereasthma |
_version_ |
1718411480883265536 |